Trump's new tariff move may raise U.S. pharma costs, with analysts warning of risks tied to EU manufacturing and shifting healthcare policies.
Oregon Senator Ron Wyden speaking out against Trump’s tariffs on the senate floor Wednesday hours before the president rolled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback